Mitochondria-Targeted Multifunctional Nanoprodrugs by Inhibiting Metabolic Reprogramming for Combating Cisplatin-Resistant Lung Cancer
ACS Nano · 13.08.2024 · 18 (32) · 21156-21170
DOI: 10.1021/acsnano.4c04024 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Nano, online erschienen am 01.08.2024. Verfasst von Haibin Lu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Jilin University School of Pharmaceutical Sciences, Changchun 130021, China. Hauptthemen laut MEDLINE: Cisplatin, Mitochondria, Antineoplastic Agents, Lung Neoplasms. Die Arbeit wurde bisher 99-mal zitiert (Crossref) und nennt 50 Literaturangaben. Gefördert von: Jilin Provincial Scientific and Technological Development Program.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Jilin University School of Pharmaceutical Sciences, Changchun 130021, China.
- Department of Otolaryngology Head and Neck Surgery, The Second Hospital of Jilin University, Changchun 130041, China.
- Scientific Research Center, China-Japan Union Hospital of Jilin University, Changchun 130033, China.
ORCID-Profile: Xupeng Mu
Förderung
- Jilin Provincial Scientific and Technological Development Program
Zitieren
APA
Lu, H., Tong, W., Jiang, M., Liu, H., Meng, C., Wang, K., & Mu, X. (2024). Mitochondria-Targeted Multifunctional Nanoprodrugs by Inhibiting Metabolic Reprogramming for Combating Cisplatin-Resistant Lung Cancer. ACS Nano, 18(32), 21156-21170. https://doi.org/10.1021/acsnano.4c04024
Vancouver
Lu H, Tong W, Jiang M, Liu H, Meng C, Wang K, et al. Mitochondria-Targeted Multifunctional Nanoprodrugs by Inhibiting Metabolic Reprogramming for Combating Cisplatin-Resistant Lung Cancer. ACS Nano. 2024;18(32):21156-21170. doi:10.1021/acsnano.4c04024
BibTeX
@article{Lu2024,
author = {Lu, Haibin and Tong, Weifang and Jiang, Meixu and Liu, Huimin and Meng, Chen and Wang, Kai and Mu, Xupeng},
title = {Mitochondria-Targeted Multifunctional Nanoprodrugs by Inhibiting Metabolic Reprogramming for Combating Cisplatin-Resistant Lung Cancer},
journal = {ACS Nano},
year = {2024},
volume = {18},
number = {32},
pages = {21156--21170},
doi = {10.1021/acsnano.4c04024}
}
EUVIMED